支架回收器管道 - 发展阶段、细分市场、地区和国家、监管途径、主要参与者（2024 年版）

该报告提供了有关支架取回器管道的全面信息，包括处于不同开发阶段的产品的比较分析以及正在进行的临床试验的数据。

目录

第1章 目录

第2章简介

第3章 开发中产品

• 支架回收器 - 管道产品：依开发阶段划分
• 支架回收器 - 管道产品：按地区
• 支架回收器 - 管道产品：依监管途径
• 支架回收器 - 管道产品：依预计核准日期
• 支架回收器 - 正在进行的临床试验

第4章 支架回收器-各公司在研产品

• 支架回收器公司 - 管道产品：依开发阶段
• 支架回收器 - 管道产品：依开发阶段划分

第5章 支架取回器企业及产品概述

• Amnis Therapeutics Ltd：公司概况
  • Amnis Therapeutics Ltd：管道产品和正在进行的临床试验概述
• Biomedical Solutions Inc：公司概况
  • Biomedical Solutions Inc：管道产品和正在进行的临床试验概述
• Capital Medical University：公司概况
  • Capital Medical University：在研产品及正在进行的临床试验概况
• HeMo Bioengineering Ltd：公司概况
  • HeMo Bioengineering Ltd：管道产品和正在进行的临床试验概述
• Insera Therapeutics LLC：公司概况
  • Insera Therapeutics LLC：管道产品和正在进行的临床试验概述
• Medtronic Plc：公司概况
  • Medtronic Plc：管道产品和正在进行的临床试验概述
• MicroPort NeuroScientific Corp：公司概况
  • MicroPort NeuroScientific Corp：在研产品和正在进行的临床试验概述
• MiVi Neuroscience Inc：公司概况
  • MiVi Neuroscience Inc：管道产品和正在进行的临床试验概述
• Nanjing Kanite Medical Technology Co Ltd：公司概况
  • Nanjing Kanite Medical Technology Co Ltd：：在研产品概况及正在进行的临床试验
• NeuroVasc Technologies Inc：公司概况
  • NeuroVasc Technologies Inc：管道产品和正在进行的临床试验概述
• OrbusNeich：公司概况
  • OrbusNeich：管道产品和正在进行的临床试验概述
• Perflow Medical 有限公司：公司概况
  • Perflow Medical, Ltd.：管道产品和正在进行的临床试验概述
• Shanghai MicroPort Medical Group Co Ltd：公司概况
  • Shanghai MicroPort Medical Group Co Ltd：在研产品及正在进行的临床试验概述
• SinoMedCare Biotech Co Ltd：公司概况
  • SinoMedCare Biotech Co Ltd：在研产品及正在进行的临床试验概述
• Sree Chitra Tirunal Institute for Medical Sciences & Technology：公司概况
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology：管道产品和正在进行的临床试验概述
• Triticum Medical Ltd.：公司概况
  • Triticum Medical Ltd.：管道产品和正在进行的临床试验概述
• Vesalio LLC：公司概况
  • Vesalio LLC：管道产品和正在进行的临床试验概述
• Zhejiang Kindly Medical Devices Co Ltd：公司概况
  • Zhejiang Kindly Medical Devices Co Ltd：在研产品及正在进行的临床试验概况
• Zylox-Tonbridge Medical Technology Co Ltd：公司概况
  • Zylox-Tonbridge Medical Technology Co Ltd：管道产品概述和正在进行的临床试验

第 6 章支架回收器 - 最新发展

• 2024 年 9 月 4 日：Rapid Medical 报告使用 TIGERTRIEVER13 对 DISTALS 试验进行中期安全分析，并未发现中型血管阻塞的安全性问题
• 2024 年 8 月 26 日：Zylox-Tonbridge 公布 2024 年中期业绩表现强劲，实现显着增长和盈利
• 2024 年 7 月 10 日：继 Neva Net 5.5 MM 在国际上取得成功后，Vesalio 推出 Neva Net 4.0 MM
• 2024 年 5 月 14 日：Rapid Medical 使用世界上第一台机器人血栓清除设备成功进行了缺血性中风手术
• 2024 年 2 月 5 日：Wallabyphenox 透过 Prost 试验大胆树立了实证医学的新基准
• 2023 年 12 月 14 日：Rapid Medical 的血管重建装置在日本获得批准
• 2023 年 11 月 16 日：Rapid Medical 的 TIGERTRIEVER 为患有 ICAD 的缺血性中风患者带来了首次成功
• 2023 年 11 月 5 日：phenox 的预设 LITE 血栓切除装置获得额外 510(K) 批准

第7章附录

GlobalData's Medical Devices sector report, "Stent Retrievers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Stent Retrievers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Stent retrievers are deployed by a catheter that is threaded through the clot. Once the stent is fully deployed, the stent is retrieved with the clot attached.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Stent Retrievers under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Stent Retrievers and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Stent Retrievers under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Stent Retrievers Overview

3 Products under Development

• 3.1 Stent Retrievers - Pipeline Products by Stage of Development
• 3.2 Stent Retrievers - Pipeline Products by Territory
• 3.3 Stent Retrievers - Pipeline Products by Regulatory Path
• 3.4 Stent Retrievers - Pipeline Products by Estimated Approval Date
• 3.5 Stent Retrievers - Ongoing Clinical Trials

4 Stent Retrievers - Pipeline Products under Development by Companies

• 4.1 Stent Retrievers Companies - Pipeline Products by Stage of Development
• 4.2 Stent Retrievers - Pipeline Products by Stage of Development

5 Stent Retrievers Companies and Product Overview

• 5.1 Amnis Therapeutics Ltd Company Overview
  • 5.1.1 Amnis Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Biomedical Solutions Inc Company Overview
  • 5.2.1 Biomedical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Capital Medical University Company Overview
  • 5.3.1 Capital Medical University Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 HeMo Bioengineering Ltd Company Overview
  • 5.4.1 HeMo Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Insera Therapeutics LLC Company Overview
  • 5.5.1 Insera Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Medtronic Plc Company Overview
  • 5.6.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 MicroPort NeuroScientific Corp Company Overview
  • 5.7.1 MicroPort NeuroScientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 MiVi Neuroscience Inc Company Overview
  • 5.8.1 MiVi Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Nanjing Kanite Medical Technology Co Ltd Company Overview
  • 5.9.1 Nanjing Kanite Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 NeuroVasc Technologies Inc Company Overview
  • 5.10.1 NeuroVasc Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 OrbusNeich Company Overview
  • 5.11.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Perflow Medical, Ltd. Company Overview
  • 5.12.1 Perflow Medical, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Shanghai MicroPort Medical Group Co Ltd Company Overview
  • 5.13.1 Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 SinoMedCare Biotech Co Ltd Company Overview
  • 5.14.1 SinoMedCare Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
  • 5.15.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Triticum Medical Ltd. Company Overview
  • 5.16.1 Triticum Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 Vesalio LLC Company Overview
  • 5.17.1 Vesalio LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 Zhejiang Kindly Medical Devices Co Ltd Company Overview
  • 5.18.1 Zhejiang Kindly Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
  • 5.19.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Stent Retrievers- Recent Developments

• 6.1 Sep 04, 2024: Rapid Medical Reports No Safety Concerns for Medium Vessel Occlusions in the Interim Safety Analysis of the DISTALS Study with TIGERTRIEVER13
• 6.2 Aug 26, 2024: Zylox-Tonbridge Reports Strong Interim Financial Results for 2024, Achieving Significant Growth and Profitability
• 6.3 Jul 10, 2024: Vesalio Introduces Neva Net 4.0 MM Following International Success of Neva Net 5.5 MM
• 6.4 May 14, 2024: Rapid Medical Completes Successful Ischemic Stroke Procedures with the World's First Robotic Thrombectomy Device
• 6.5 Feb 05, 2024: Wallabyphenox Boldly Sets New Benchmark in Evidence-Based Medicine with the Prost Trial
• 6.6 Dec 14, 2023: Rapid Medical receives Japanese approval for revascularisation device
• 6.7 Nov 16, 2023: Rapid Medical's TIGERTRIEVER Delivers First-Pass Success in Challenging Ischemic Stroke Patients with ICAD
• 6.8 Nov 05, 2023: phenox Receives Additional 510(K) Clearance for pREset LITE Thrombectomy Device

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

• Stent Retrievers - Pipeline Products by Stage of Development
• Stent Retrievers - Pipeline Products by Territory
• Stent Retrievers - Pipeline Products by Regulatory Path
• Stent Retrievers - Pipeline Products by Estimated Approval Date
• Stent Retrievers - Ongoing Clinical Trials
• Stent Retrievers Companies - Pipeline Products by Stage of Development
• Stent Retrievers - Pipeline Products by Stage of Development
• Glossary

List of Figures

• Stent Retrievers - Pipeline Products by Stage of Development
• Stent Retrievers - Pipeline Products by Territory
• Stent Retrievers - Pipeline Products by Regulatory Path
• Stent Retrievers - Pipeline Products by Estimated Approval Date
• Stent Retrievers - Ongoing Clinical Trials